ExLibris header image
SFX Logo
Title: Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans
Source:

Pharmacogenomics Journal [1470-269X] Hernandez, W yr:2013


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Johnson, J A A. "Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data." New England Journal of Medicine, The 360.8 (2009): 753-764. Link to SFX for this item
2. Weitzel, K. "Pharmacogenomics in cardiology - genetics and drug response: 10 years of progress." Future cardiology 11.3 (2015): 281-286. Link to SFX for this item
3. Nagai, R. "Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms." Pharmacogenomics 16.3 (2015): 217-25. Link to SFX for this item
4. Suarez Kurtz, G. "Pharmacogenomics of Warfarin in Populations of African Descent." British journal of clinical pharmacology 75.2 (2012): 334-346. Link to Full Text for this item Link to SFX for this item
5. Mallal, S. "HLA-B*5701 screening for hypersensitivity to abacavir." New England Journal of Medicine, The 358.6 (2008): 568-579. Link to SFX for this item
6. Gage, B. "Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin." Clinical pharmacology and therapeutics 84.3 (2008): 326-31. Link to SFX for this item
7. Salinger, Kenneth H. "Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulation." Pharmacogenetics and genomics 19.12 (2009): 965-971. Link to SFX for this item
8. Higashi, Mitchell K K. "Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy." JAMA 287.13 (2002): 1690-8. Link to SFX for this item
9. Sconce, Elizabeth A A. "The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen." Blood 106.7 (2005): 2329-33. Link to SFX for this item
10. "The pharmacogenomics of warfarin from the COAG and EU-PACT: where do we go from here?" Personalized medicine. 11.3: 247-249. Link to SFX for this item
11. Guo, C. "Pharmacogenomics signature: A novel strategy on the individual differences in drug response." Cancer letters. 420: 190-194. Link to SFX for this item
12. "Correlation between rivaroxaban (Xarelto) plasma activity, patient clinical variables and outcomes in a South African centre." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 106.10: 1017-1020. Link to SFX for this item
13. Blagec, K. "Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study." PeerJ 4 (2016). Link to Full Text for this item Link to SFX for this item
14. Feng, Q. "Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting." Pharmacogenomics 15.14 (2014): 1739-1747. Link to SFX for this item
15. Black, A. "Frequency of CYP2C9 polymorphisms in polynesian people and potential relevance to management of gout with benzbromarone." Joint bone spine 81.2 (2013): 160-163. Link to SFX for this item
16. Hor, S Y Y. "PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients." The pharmacogenomics journal (2008): 139-46. Link to Full Text for this item Link to SFX for this item
17. Cavallari, Larisa H. "Predictors of unstable anticoagulation in African Americans." Journal of thrombosis and thrombolysis 27.4 (2008): 430-437. Link to SFX for this item
18. Gage, Elena F. "Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation." Stroke 37.4 (2006): 1070-4. Link to SFX for this item
19. Yin, T. "Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives." Thrombosis Research 120.1 (2007): 1-10. Link to SFX for this item
20. Wadelius, M. "Pharmacogenetics of warfarin: current status and future challenges." The pharmacogenomics journal 7.2 (2007): 99-111. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.